Zobrazeno 1 - 7
of 7
pro vyhledávání: '"R A, Zabinski"'
Publikováno v:
Antimicrobial Agents and Chemotherapy. 37:2454-2458
An in vitro pharmacodynamic system has been successfully adapted to simulate in vivo antimicrobial pharmacokinetics under anaerobic conditions. This system was used to perform time-kill kinetic studies which were designed to compare the activity of t
Publikováno v:
Antimicrobial Agents and Chemotherapy. 37:1377-1379
To prove the utility of antibiotic-removal beads in separating antibiotics from bacterial samples, Escherichia coli ATCC 25922 was exposed to five separate quinolones before and after each was exposed to antibiotic-removal beads. Plates treated with
Autor:
W G, Bensen, S Z, Zhao, T A, Burke, R A, Zabinski, R W, Makuch, C J, Maurath, N M, Agrawal, G S, Geis
Publikováno v:
The Journal of rheumatology. 27(8)
To determine the upper gastrointestinal (GI) tolerability of celecoxib, naproxen, and placebo in patients with rheumatoid arthritis (RA) and osteoarthritis (OA).An analysis of 5, 12-week, randomized, double blind, parallel group, placebo controlled c
Publikováno v:
Antimicrobial agents and chemotherapy. 39(2)
A previously established in vitro pharmacodynamic system was used to evaluate the antistaphylococcal activities of five fluoroquinolones under both aerobic and anaerobic conditions. Staphylococcus aureus ATCC 29213 was exposed to a 5-micrograms/ml co
Publikováno v:
Journal of clinical pharmacology. 32(12)
Minimum inhibitory concentration testing is the most common standard used to evaluate antibacterial activity of antimicrobials against specific pathogens. The consideration of pharmacodynamic factors in conjunction with these tests can improve the ma
Publikováno v:
Pharmacotherapy. 12(6 Pt 2)
The primary focus of the pharmaceutical industry in past years has been on developing more potent antibiotics rather than on establishing optimum therapy with currently available agents. Concepts that can be used to tailor patient- and pathogen-speci
Publikováno v:
The Journal of biological chemistry. 249(19)